Pixalate Releases Ad
Pixalate Releases Ad Industry’s First Made For Advertising (MFA) Mobile Apps Report: $7.5 Million in Estimated Global Ad Spend Went to Likely MFA Mobile Apps Across Google & Apple App Stores in Q1 2024
12 juin 2024 08h00 HE | Pixalate Inc.
LONDON, June 12, 2024 (GLOBE NEWSWIRE) -- Pixalate, the global market-leading ad fraud protection, privacy, and compliance analytics platform, today released the Q1 2024 Made For Advertising (MFA)...
nokialogo.png
Nokia Report reveals enterprises are scaling private wireless for additional uses cases and industrial sites
12 juin 2024 03h00 HE | Nokia Oyj
Nokia Report reveals enterprises are scaling private wireless for additional uses cases and industrial sites 45% of the organizations are leveraging private wireless to support more use cases than...
Pixalate Releases Ma
Pixalate Releases Made For Advertising (MFA) Connected TV (CTV) Apps Ad Spend Report: $64 Million in Estimated Global Ad Spend Went to Likely MFA CTV Apps Across Roku, Amazon Fire TV, Apple TV, and Samsung Smart TV in Q1 2024
11 juin 2024 08h05 HE | Pixalate Inc.
LONDON, June 11, 2024 (GLOBE NEWSWIRE) -- Pixalate, the global market-leading ad fraud protection, privacy, and compliance analytics platform, today released the Q1 2024 Made For Advertising (MFA)...
LPR_Logo_K.png
London Research & Pharmaceuticals (LRP) Presents the Advancement of LRP-661, Their Lead Drug Candidate, at the Seventeenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XVII) Conference in Madrid, Spain, 5-8 May 2024
10 juin 2024 14h33 HE | London Research and Pharmaceuticals
London Research & Pharmaceuticals Presents Advancement of LRP-661, Their Lead Drug Candidate, at the New Antiepileptic Drug Conference in Madrid, Spain
Qu Biologics.png
Seniors in Metro Vancouver Invited to Participate in a Clinical Trial Assessing a New Immunomodulator Designed to Restore Immune Function in the Elderly
07 juin 2024 20h18 HE | Qu Biologics, Inc.
Vancouver, BC, June 07, 2024 (GLOBE NEWSWIRE) -- Qu Biologics Inc., a Burnaby-based clinical-stage biotechnology company, is pleased to announce that the RESILIENCE Study, a clinical trial...
Pixalate Releases Ap
Pixalate Releases April 2024 Website MFA Risk Index for Open Programmatic Sellers (SSPs): Google AdExchange, Magnite Have Highest MFA Risk in April 2024
06 juin 2024 10h03 HE | Pixalate Inc.
LONDON, June 06, 2024 (GLOBE NEWSWIRE) -- Pixalate, the global market-leading ad fraud protection, privacy, and compliance analytics platform, today released the April 2024 Web MFA Risk Analysis:...
BioNTX StandardMed_Res.jpg
BioNTX Announces 10th Annual iC³® Life Science & Healthcare Innovation Summit
06 juin 2024 10h00 HE | Bio North Texas
BioNTX, the leading biotechnology trade organization in North Texas, is thrilled to announce the 10th Annual iC³® Life Science Summit.
Qu Biologics.png
Qu Biologics and Foundation Medicine Collaborate to Impact the Care of Patients with Late-Stage Colorectal Cancer
06 juin 2024 08h00 HE | Qu Biologics, Inc.
BURNABY, British Columbia, June 06, 2024 (GLOBE NEWSWIRE) -- Qu Biologics Inc., a clinical stage biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a novel platform of...
Pixalate Releases Gl
Pixalate Releases Global Q1 2024 Made For Advertising (MFA) Websites Ad Spend Report: 10% of Global Open Programmatic Ad Spend Went to Likely MFA Sites in March 2024, 12% in North America, Followed by EMEA (8%), LATAM (8%), and APAC (6%)
05 juin 2024 14h17 HE | Pixalate Inc.
LONDON, June 05, 2024 (GLOBE NEWSWIRE) -- Pixalate, the global market-leading ad fraud protection, privacy, and compliance analytics platform, today released the Q1 2024 Made For Advertising (MFA)...
AMEC Chair Handover 2024
AMEC Announces New Chair AMEC, the world’s largest media intelligence and insights professional body announced Raina Lazarova, Co-Founder of Ruepoint as new Chair